Hepion Pharmaceuticals (HEPA) Financial Statements
Hepion Pharmaceuticals Financial Overview
Hepion Pharmaceuticals's market cap is currently $17.68M. The company's EPS TTM is $-0.24; its P/E ratio is -0.74; Hepion Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -4.16M | $ -19.35M | $ -48.45M | $ -45.49M | $ -30.40M |
| EBITDA | $ -3.73M | $ -14.88M | $ -49.26M | $ -45.00M | $ -32.63M |
| Net Income | $ -8.28M | $ -13.19M | $ -48.93M | $ -42.20M | $ -32.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.83M | $ 406.41K | $ 14.79M | $ 51.19M | $ 91.35M |
| Total Assets | $ 3.07M | $ 1.61M | $ 18.09M | $ 60.24M | $ 103.55M |
| Total Debt | $ 54.07K | $ 2.90M | $ 209.02K | $ 53.61K | $ 316.99K |
| Net Debt | $ -1.77M | $ 2.49M | $ -14.58M | $ -51.14M | $ -91.03M |
| Total Liabilities | $ 402.40K | $ 3.48M | $ 10.81M | $ 10.39M | $ 10.56M |
| Stockholders' Equity | $ 2.67M | $ -1.86M | $ 7.28M | $ 49.86M | $ 93.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.27M | $ -18.22M | $ -40.90M | $ -34.98M | $ -31.35M |
| Operating Cash Flow | $ -3.27M | $ -18.22M | $ -40.89M | $ -34.96M | $ -31.22M |
| Investing Cash Flow | $ -132.12K | $ -600.00K | $ -14.30K | $ -14.07K | $ -130.41K |
| Financing Cash Flow | $ 4.83M | $ 4.35M | $ 4.49M | $ -5.14M | $ 81.98M |
Currency in USD
